Skip to content

Staar Surgical STAA Inventory (FIFO Basis)

Inventory (FIFO Basis) at other companies

Kroger logo
KrogerKR
$9.88B+4.4%
BJ's Restaurants logo
BJ's RestaurantsBJRI
$12.82M+3.8%
Koppers Holdings logo
Koppers HoldingsKOP
51%-6.0pp
ARS Pharmaceuticals, Inc. logo
ARS Pharmaceuticals, Inc.SPRY
$8.82M
ITT logo
ITTITT
$976.4M+52.9%
HF Sinclair logo
HF SinclairDINO
$3.27B+9.9%

Other financials

Income statement

See full
Revenue$93.5M+120%
Gross profit$68.9M+146%
Operating income$8.0M+114%
Net income$5.2M+110%
EPS (diluted)$0.10+109%

Balance sheet

See full
Cash & equivalents$131.9M-23.8%
Total debt$37.3M+1.7%
Total equity$352.4M+0.7%
Total assets$451.1M-1.4%

Cash flow

See full
Operating cash flow-$21.7M-278%
CapEx$443.0K-69.8%
Free cash flow-$22.1M-207%

Valuation

See full
Market cap$1.44B+77.9%
Enterprise value$1.35B+100.0%
P/S+2.1×

Profitability

See full
Gross margin76.9%+2.9pp
Operating margin-9.1%-3.5pp
Net margin-7.2%-3.0pp
FCF margin-19.6%+55.9pp

Returns & leverage

See full
Return on equity-6%-2.4pp
Debt / equity0.1×0.0×
Current ratio5.1×+0.3×

Where this comes from

Reported directly by Staar Surgical in its filing.

Tagged under the XBRL concept us-gaap:FIFOInventoryAmount.

The official record: Staar Surgical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Staar Surgical's inventory (fifo basis).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Staar Surgical's inventory (FIFO basis)?
Staar Surgical (STAA) reported inventory (FIFO basis) of $49.78M in Q1 2026.
How has Staar Surgical's inventory (FIFO basis) changed year-over-year?
Staar Surgical's inventory (FIFO basis) increased by 3.4% year-over-year, from $48.14M to $49.78M.
What is the long-term trend for Staar Surgical's inventory (FIFO basis)?
Over 5 years (2020 to 2025), Staar Surgical's inventory (FIFO basis) has grown at a 25.1% compound annual growth rate (CAGR), from $18.11M to $55.5M.
What does inventory (FIFO basis) mean?
This represents the total value of finished goods, work-in-progress, and raw materials calculated using the First-In, First-Out cost flow assumption. It reflects the current cost of inventory on the balance sheet, assuming the oldest items are sold first. This metric is critical for assessing supply chain efficiency and potential obsolescence risk in medical device manufacturing.